Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$454K Buy
4,565
+1
+0% +$103 0.33% 45
2024
Q3
$518K Hold
4,564
0.4% 42
2024
Q2
$565K Buy
4,564
+1
+0% +$129 0.46% 39
2024
Q1
$602K Sell
4,563
-663
-13% -$81.7K 0.5% 40
2023
Q4
$570K Sell
5,226
-37
-0.7% -$3.84K 0.51% 39
2023
Q3
$542K Hold
5,263
0.51% 39
2023
Q2
$607K Buy
5,263
+79
+2% +$8.97K 0.55% 35
2023
Q1
$552K Sell
5,184
-28
-0.5% -$3.02K 0.52% 36
2022
Q4
$578K Sell
5,212
-108
-2% -$11K 0.58% 34
2022
Q3
$458K Sell
5,320
-21
-0.4% -$1.88K 0.52% 35
2022
Q2
$487K Sell
5,341
-335
-6% -$29.7K 0.54% 35
2022
Q1
$466K Hold
5,676
0.44% 45
2021
Q4
$435K Buy
+5,676
New +$452K 0.41% 45

Other funds holding MRK

Unionview LLC's MRK Position: Q4 2024 in Review

Unionview LLC increased its Merck (MRK) stake by 0.02% in Q4 2024, buying an estimated $103 and bringing the position to 4,565 shares worth $454K. The position accounts for 0.33% of the portfolio, ranked #45.

Unionview LLC first reported a position in MRK in Q4 2021 and has held it in 13 quarters since. The position peaked at $607K in Q2 2023. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Unionview LLC held 4,565 shares of Merck worth $454K as of Q4 2024.
  • Unionview LLC bought 1 Merck share in Q4 2024, an estimated $103.
  • Merck made up 0.33% of Unionview LLC's portfolio in Q4 2024, its #45 holding.
  • Unionview LLC first reported a position in Merck in Q4 2021 and has held it in 13 quarters since.
  • Unionview LLC's Merck position peaked at $607K in Q2 2023.
  • 3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Unionview LLC's 13F filing for Q4 2024, filed 3 Feb 2025.